Table 1.
Baseline demographics
| n = 39 | |
|---|---|
| Age at implant (yrs) | 16 (4–21) |
| Weight (kg) | 62 (15–134) |
| Body surface area (m2) | 1.62 ± 0.36 |
| Male (n, %) | 27 (69%) |
| Impella device type | |
| 2.5 | 15 (38%) |
| CP | 19 (49%) |
| 5.0 | 5 (13%) |
| Diagnosis | |
| Congenital heart disease | 11 (28%) |
| Post heart transplant | 10 (26%) |
| Dilated cardiomyopathy | 9 (23%) |
| Myocarditis | 4 (10%) |
| Post-partum cardiomyopathy | 2 (5%) |
| Arrhythmia | 2 (5%) |
| Drug overdose | 1 (3%) |
| Indication for support | |
| Cardiogenic shock | 28 (72%) |
| Planned procedural support | 4 (10%) |
| Refractory heart failure | 6 (15%) |
| Arrhythmia | 1 (3%) |
| Ejection Fraction (%) | 15 (5–51) |
Data are presented as mean±SD, median (minimum-maximum) or number (%)